Health care workers (HCW) are a high-risk population to acquire SARS-CoV-2 infection
from patients or other fellow HCW. This study aims at estimating the seroprevalence against …

Naturally acquired immunity to falciparum malaria protects millions of people routinely
exposed to Plasmodium falciparum infection from severe disease and death. There is no clear …

Background The RTS,S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …

Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …

Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual characteristics
influencing it, including the impact of pre-existing antibodies to human coronaviruses …

Background We performed a population-based study to describe the impact of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on pregnancy outcomes. …

Background Current recommendations to prevent malaria in African pregnant women rely on
insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp). However, there …

Background Maternal mortality is a major health problem concentrated in resource-poor
regions. Accurate data on its causes using rigorous methods is lacking, but is essential to guide …

Background Two doses of mRNA vaccination have shown >94% efficacy at preventing
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …

Background Low concentrations of the anti-inflammatory protein CC16 (approved symbol
SCGB1A1) in serum have been associated with accelerated decline in forced expiratory …